Dentsply Sirona (XRAY) Stock Drops As Revenue Weakens Despite Profit Rebound
DENTSPLY SIRONA, Inc. XRAY | 0.00 |
Dentsply Sirona walked into this quarter with a turnaround label and a cheap stock narrative. The share price dropped 8% to about US$12 after the release, yet the headline from the numbers is quieter and more mixed than that move suggests. Revenue came in at US$898m and adjusted earnings per share held at US$0.52, helped by a one off tariff refund. For a company still carrying losses on a trailing twelve month basis, this update was less about a clean reset and more about whether the early steps of the recovery plan are taking hold.
Interested in DENTSPLY SIRONA as a turnaround story but cautious about a company that is still loss making on a trailing basis? Compare it with our list of 78 resilient stocks with low risk scores for ideas with steadier profiles.
Q2 2026 Earnings Summary
- Revenue Q2 2026 vs. Q2 2025: US$898m vs. US$936m (declined 4.1%)
- Net Income Q2 2026 vs. Q2 2025: US$37m vs. a loss of US$45m (returned to profit)
- Basic EPS Q2 2026 vs. Q2 2025: US$0.19 vs. a loss of US$0.23 per share (moved back into positive territory)
- Operating Cash Flow Q2 2026 vs. Q2 2025: US$99m vs. US$48m (more than doubled, helped by tariff refunds and working capital)
Prefer clean visuals instead of another block of dense earnings text? View DENTSPLY SIRONA's valuation and overall financial picture in our company report for DENTSPLY SIRONA.
Dentsply Sirona Turnaround: Early Proof Points, Clear Gaps
The bullish story on Dentsply Sirona is that a tighter execution focus and digital adoption will steadily lift margins and cash generation even before growth improves. This quarter offers partial support. Net income swung from a loss to a US$37m profit and operating cash flow rose to US$99m, helped by US$44m of tariff refunds and working capital progress. Adjusted EPS held at US$0.52, although about a third of that reflects the one off refund, which limits how much credit you can give to underlying earnings quality.
Where the bullish narrative is less supported is on growth and digital inflection. Revenue declined 4.1% and constant currency trends were weaker, while CAD/CAM and implants both fell. Management kept full year guidance and highlighted new dealer partnerships and DS Core pilots, which signals confidence in the plan. However, the core milestone of stabilising top line performance is not yet met.
Reveal whether Wall Street shares this Dentsply Sirona turnaround argument or is fading it at these levels. See the consensus price target analysis for DENTSPLY SIRONADentsply Sirona Bear Case: Revenue Slippage Validates Skeptics
The core bearish worry on Dentsply Sirona is that weakening demand for premium equipment and implants, coupled with rising competition and cost pressure, will keep revenue under strain and turn the stock into a value trap. This quarter leans in that direction. Group sales fell 4.1% reported and 6.3% in constant currency, with CAD/CAM and premium implants both declining while growth skewed to value implant brands and Wellspect. That mix shift speaks directly to concerns about pricing power and premium positioning.
Bears also argue that execution risk and regulatory and cost headwinds will cap margin progress. Adjusted EPS was flat at US$0.52 and relied on a US$44m tariff refund worth about US$0.17 per share. Operating cash flow improvement similarly leaned on that refund. With guidance merely reiterated and Q3 flagged as softer than Q2, the key milestone of clear, organic earnings traction remains unmet.
With Dentsply Sirona still loss making on a trailing basis and revenue growth running at just 1.6% per year, it is important to verify whether the balance sheet can support any turnaround. Check the full solvency and liquidity picture in our financial health analysis of DENTSPLY SIRONA stock.Stay Ahead With Simply Wall St
If DENTSPLY SIRONA's mix of early turnaround signs and ongoing risks has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and wait for an entry point that fits your plan. After you build a position, keep your decisions grounded with a Portfolio Command Center that cuts through noise and focuses on key fundamental changes. For longer term perspective, use the Community to see how other investors are interpreting the same data and earnings updates. By spotting potential catalysts and red flags early, you may improve your ability to stay informed about market developments.
Seeking Alternatives Beyond Dentsply Sirona?
Fresh breakout stories often move fast and leave latecomers caught watching from the sidelines. Use these focused lists while the data still matters and get in early.
- Spot cash rich companies quietly building momentum before the crowd notices by scanning our curated list of solid balance sheet and fundamentals stocks (49 results).
- Ride structural themes with stocks positioned for long term demand shifts by checking the focused list of 36 power grid technology and infrastructure stocks.
- Target fast growing companies where profit and AI momentum already meet by reviewing the hand picked group of 68 profitable AI stocks that aren't just burning cash.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
